Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley B Boam

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Medical Devices|May 10, 2006
Regulatory issues facing the development of drug-eluting stents: a US FDA perspectiveAshley B Boam
The New England Journal of Medicine|February 14, 2007
Stent thrombosis redux--the FDA perspectiveAndrew Farb, Ashley B Boam
Circulation. Cardiovascular Interventions|December 25, 2009
Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory reviewDavid E Kandzari, Andrew Farb, Ashley B Boam
Food and Drug Law Journal|August 16, 2005
Challenges in regulating breakthrough medical devicesNeal I Muni, Thomas P Gross, Ashley B Boam, et al.
JACC. Cardiovascular Interventions|May 21, 2011
The academic research consortium governance charterMitchell W Krucoff, Roxana Mehran, Gerrit-Anne van Es, et al.
American Heart Journal|May 3, 2005
Coronary drug-eluting stent development: issues in trial designNeal I Muni, Robert M Califf, Jonette R Foy, et al.
Journal of Cataract and Refractive Surgery|March 29, 2003
Retrospective evaluation of intraocular lenses in adults younger than 60 yearsAshley B Boam, Malvina B Eydelman, Flora C Lum, et al.
International Journal of Pharmaceutics|May 2, 2022
An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the USAdam C Fisher, William Liu, Andreas Schick, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Medical Devices|May 10, 2006
Regulatory issues facing the development of drug-eluting stents: a US FDA perspectiveAshley B Boam
The New England Journal of Medicine|February 14, 2007
Stent thrombosis redux--the FDA perspectiveAndrew Farb, Ashley B Boam
Circulation. Cardiovascular Interventions|December 25, 2009
Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory reviewDavid E Kandzari, Andrew Farb, Ashley B Boam
Food and Drug Law Journal|August 16, 2005
Challenges in regulating breakthrough medical devicesNeal I Muni, Thomas P Gross, Ashley B Boam, et al.
JACC. Cardiovascular Interventions|May 21, 2011
The academic research consortium governance charterMitchell W Krucoff, Roxana Mehran, Gerrit-Anne van Es, et al.
American Heart Journal|May 3, 2005
Coronary drug-eluting stent development: issues in trial designNeal I Muni, Robert M Califf, Jonette R Foy, et al.
Journal of Cataract and Refractive Surgery|March 29, 2003
Retrospective evaluation of intraocular lenses in adults younger than 60 yearsAshley B Boam, Malvina B Eydelman, Flora C Lum, et al.
International Journal of Pharmaceutics|May 2, 2022
An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the USAdam C Fisher, William Liu, Andreas Schick, et al.
Pageof 1